Global Non-Alcoholic Steatohepatitis Epidemiology Market Forecast To 2025
Total prevalent cases of NASH in the 7MM will grow by 0.65% per year over the next 10 years, from 60,325,647 cases in 2015, to 64,273,379 cases in 2025. In the 7MM, the US will have the highest number of total prevalent cases throughout the forecast period,
January 7, 2017 /MarketersMedia/ —
Epidemiologists forecast that the total prevalent cases of NASH in the 7MM will grow by 0.65% per year over the next 10 years, from 60,325,647 cases in 2015, to 64,273,379 cases in 2025. In the 7MM, the US will have the highest number of total prevalent cases throughout the forecast period, accounting for 56.85% of all total prevalent cases in the 7MM in 2015. When analysing the individual markets, more than 85.00% of the total prevalent cases of NASH occurred in ages 20 years and older and more cases occurred in men compared with women. Epidemiologists forecast that the 7MM will see an increase in the diagnosed prevalent cases of NASH from 16,952,459 cases in 2015 to 31,000,983 cases in 2025, at the rate of 8.29%. Diagnosed prevalent cases are forecast to increase faster than total prevalent cases due to expected increase in diagnosis rate, as indicated by primary research.
Complete report on Non-Alcoholic Steatohepatitis – Epidemiology Forecast to 2025 with 10 Tables and 7 Figures, Spread across 56 pages is available at http://www.reportsnreports.com/contacts/discount.aspx?name=802467
Major Points Covered in Table of Contents
• Epidemiological Forecast for NASH (2015-2025)
• Total Prevalent Cases of NASH
• Age-Specific Total Prevalent Cases of NASH
• Sex-Specific Total Prevalent Cases of NASH
• Epidemiological Forecast Insight
• Age-Standardized Prevalence of NASH
• Strengths of the Analysis
Purchase a Copy of Report at http://www.reportsnreports.com/purchase.aspx?name=802467
Scope
The Non-Alcoholic Steatohepatitis (NASH) EpiCast Report provides an overview of the risk factors and global trends of NASH in the 7MM (US, France, Germany, Italy, Spain, UK, and Japan). It includes a 10-year epidemiological forecast for the total prevalent cases (both diagnosed and undiagnosed) of NASH segmented by age and sex. It also includes a 10-year epidemiological forecast for the diagnosed prevalent cases of NASH, which are further segmented by comorbid disorders, including obesity, diabetes mellitus type 2 (T2D), hyperlipidemia, and hypertension in these markets.
The NASH epidemiology report is written and developed by Masters- and PhD-level epidemiologists. The EpiCast Report is in-depth, high quality, transparent and market-driven, providing expert analysis of disease trends in the 7MM.
Reasons to buy
The NASH EpiCast report will allow you to –
Develop business strategies by understanding the trends shaping and driving the global NASH market. Quantify patient populations in the global NASH market to improve product design, pricing, and launch plans.
Organize sales and marketing efforts by identifying the age groups and sex that present the best opportunities for NASH therapeutics in each of the markets covered. Identify the percentage of NASH prevalent cases by comorbidity.
About Us:
ReportsnReports.com is your single source for all market research needs. Our database includes 500,000+ market research reports from over 95 leading global publishers & in-depth market research studies of over 5000 micro markets. With comprehensive information about the publishers and the industries for which they publish market research reports, we help you in your purchase decision by mapping your information needs with our huge collection of reports.
For more information, please visit http://www.reportsnreports.com/reports/802467-epicast-report-non-alcoholic-steatohepatitis-epidemiology-forecast-to-2025.html
Contact Info:
Name: Ritesh Tiwari
Email: sales@reportsandreports.com
Organization: ReportsnReports
Release ID: 159495
Copyright © 1999-2013 SproutNews.com
